Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON41676Not yet recruiting
Randomised trial in pseudoxanthoma elasticum (PXE) comparing Etidronate with Placebo (2 arms). Primary endpoint: Percentage change in 18F-NaF uptake in leg arteries. Planned start Jul 2015; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON41676.